These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Progesterone+estrogen increased the risk of dementia in postmenopausal women. Surprising results of the WHIM study]. Fried G Lakartidningen; 2003 Sep; 100(36):2742-3. PubMed ID: 14558187 [No Abstract] [Full Text] [Related]
3. Where are we with postmenopausal hormone therapy in 2005? Lam PM; Chung TK; Haines C Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243 [TBL] [Abstract][Full Text] [Related]
4. [Hormone replacement therapy in menopause and risk of breast cancer]. Clavel-Chapelon F; Hill C Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609 [TBL] [Abstract][Full Text] [Related]
5. Update in hormone therapy use in menopause. Taylor HS; Manson JE J Clin Endocrinol Metab; 2011 Feb; 96(2):255-64. PubMed ID: 21296989 [TBL] [Abstract][Full Text] [Related]
6. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [TBL] [Abstract][Full Text] [Related]
7. [Estrogen plus gestagen especially risky. Breast cancer risk doubled]. MMW Fortschr Med; 2003 Nov; 145(46):8. PubMed ID: 14699823 [No Abstract] [Full Text] [Related]
8. Action of estrogens in the aging brain: dementia and cognitive aging. Henderson VW Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598 [TBL] [Abstract][Full Text] [Related]
9. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment. Chlebowski RT; Anderson GL J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357 [No Abstract] [Full Text] [Related]
10. Postmenopausal hormone replacement therapy: does the progestin make a difference? Fylstra DL J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600 [No Abstract] [Full Text] [Related]
11. Timing of hormone therapy influences breast cancer risk. Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975 [No Abstract] [Full Text] [Related]
12. [Preventing of postmenopausal osteoporosis by hormone replacement therapy? Is the risk acceptable?]. Wirthner D; Cornuz J; Lamy O Praxis (Bern 1994); 2004 Feb; 93(9):315-20. PubMed ID: 15060972 [TBL] [Abstract][Full Text] [Related]
17. Sex steroids and breast cancer prevention. Spicer DV; Pike MC J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456 [TBL] [Abstract][Full Text] [Related]
18. Medical issues and hormone replacement therapy. Harris PF Curr Womens Health Rep; 2002 Oct; 2(5):373-81. PubMed ID: 12215310 [TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and the risk of reproductive cancers. Swan SH J Psychosom Obstet Gynaecol; 1997 Jun; 18(2):165-74. PubMed ID: 9219113 [No Abstract] [Full Text] [Related]
20. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical? Shapiro S Climacteric; 2015 Jun; 18(3):333-5. PubMed ID: 25651904 [No Abstract] [Full Text] [Related] [Next] [New Search]